SFX by Ex Libris Inc.

Title:	Structural basis for retroviral integration into nucleosomes
Source:	Nature [0028-0836] Maskell, D P yr:2015

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Cherepanov, P. "Retroviral intasome assembly and inhibition of DNA strand transfer." Nature 464.7286 (2010): 232-236.
description	2.	Summa, V. "Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection." Journal of medicinal chemistry 51.18 (2008): 5843-55.
description	3.	Cherepanov, P. "Structural insights into the retroviral DNA integration apparatus." Current opinion in structural biology 21.2 (2011): 249-256.
description	4.	GN, M. "The mechanism of retroviral integration from X-ray structures of its key intermediates." Nature 468.7321 (2010): 326-329.
description	5.	Grobler, Jay A A. "Diketo acid inhibitor mechanism and HIV-1 integrase: implications for metal binding in the active site of phosphotransferase enzymes." Proceedings of the National Academy of Sciences of the United States of America 99.10 (2002): 6661-6.
description	6.	Tokunaga, M. "Highly inclined thin illumination enables clear single-molecule imaging in cells." Nature methods 5.2 (2008): 159-161.
description	7.	Jegede, O. "HIV type 1 integrase inhibitors: From basic research to clinical implications." AIDS reviews 10.3 (2008): 172-189.
description	8.	Kassahun, K. "Metabolism and disposition in humans of raltegravir (MK-0518), an anti-AIDS drug targeting the human immunodeficiency virus 1 integrase enzyme." Drug metabolism and disposition 35.9 (2007): 1657-63.
description	9.	Esté, José A A. "HIV entry inhibitors." The lancet 370.9581 (2007): 81-8.
description	10.	Paterson, D L L. "Adherence to protease inhibitor therapy and outcomes in patients with HIV infection." Annals of internal medicine 133.1: 21-30.
description	11.	CHANTLER, PD. "THE COMBINED USE OF FRET AND CROSSLINKING TO ESTIMATE DISTANCES BETWEEN MOBILE SITES." Biophysical journal 53.2 (1988).
description	12.	Nuñez, James K. "Integrase-mediated spacer acquisition during CRISPR-Cas adaptive immunity." Nature 519.7542 (2015): 193-198.
description	13.	Doudna, Jennifer A. "Structures of Cas9 Endonucleases Reveal RNA-Mediated Conformational Activation." Science 343.6176 (2014): 1247997-1247997.
description	14.	Gupta, Saumya S. "Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration." Journal of virology 87.23 (2013): 12721-36.
description	15.	Matreyek, Kenneth A. "The Requirement for Nucleoporin NUP153 During Human Immunodeficiency Virus Type 1 Infection is Determined by the Viral Capsid." Journal of virology 85.15 (2011): 7818-7827.
description	16.	Hare, S. "Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance." Proceedings of the National Academy of Sciences of the United States of America 107.46 (2010): 20057-20062.
description	17.	Snijder-Van As, M. "A hybrid total internal reflection fluorescence and optical tweezers microscope to study cell adhesion and membrane protein dynamics of single living cells." Journal of microscopy 233.1 (2009): 84-92.
description	18.	Smith, R. "Integration Site Selection by Retroviral Vectors: Molecular Mechanism and Clinical Consequences." Human gene therapy 19.6 (2008): 557-568.
description	19.	Friedman, A. "Genome-wide high-throughput screens in functional genomics." Current opinion in genetics & development 14.5 (2004): 470-476.
description	20.	Hazuda, D J J. "Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells." Science 287.5453 (1999): 646-50.